Published in Eur J Immunol on August 01, 2001
Immunomodulatory functions of type I interferons. Nat Rev Immunol (2012) 3.73
Celiac disease: pathogenesis of a model immunogenetic disease. J Clin Invest (2007) 2.28
Dendritic cells in intestinal homeostasis and disease. J Clin Invest (2009) 1.83
Regulation of the T helper cell type 1 transcription factor T-bet in coeliac disease mucosa. Gut (2004) 0.96
Systemic administration of the chemokine macrophage inflammatory protein 1alpha exacerbates inflammatory bowel disease in a mouse model. Gut (2005) 0.95
Parallels between pathogens and gluten peptides in celiac sprue. PLoS Pathog (2008) 0.91
The role of type I interferons in intestinal infection, homeostasis, and inflammation. Immunol Rev (2014) 0.89
Constitutive activation of the signal transducer and activator of transcription pathway in celiac disease lesions. Am J Pathol (2003) 0.87
Bioinformatics analysis of the factors controlling type I IFN gene expression in autoimmune disease and virus-induced immunity. Front Immunol (2013) 0.82
Reduced number and function of peripheral dendritic cells in coeliac disease. Clin Exp Immunol (2007) 0.79
The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet. Semin Immunopathol (2012) 0.78
The role of celiac disease in severity of liver disorders and effect of a gluten free diet on diseases improvement. Hepat Mon (2013) 0.78
Ingested Type I Interferon-State of the Art as Treatment for Autoimmunity Part 2. Pharmaceuticals (Basel) (2010) 0.75
Type I and III Interferon in the Gut: Tight Balance between Host Protection and Immunopathology. Front Immunol (2017) 0.75
Effects of Interferons and Viruses on Metabolism. Front Immunol (2016) 0.75
Effector and suppressor T cells in celiac disease. World J Gastroenterol (2015) 0.75
Celiac Disease-Related Inflammation Is Marked by Reduction of Nkp44/Nkp46-Double Positive Natural Killer Cells. PLoS One (2016) 0.75
Interferon-Alpha Promotes Th1 Response and Epithelial Apoptosis via Inflammasome Activation in Human Intestinal Mucosa. Cell Mol Gastroenterol Hepatol (2016) 0.75
Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet (1992) 6.66
Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease. Gut (1993) 3.25
Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa. Immunology (1993) 3.20
Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease. Gut (1991) 2.98
Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology (1994) 2.85
Expression of disulfide-linked and non-disulfide-linked forms of the T cell receptor gamma/delta heterodimer in human intestinal intraepithelial lymphocytes. Eur J Immunol (1989) 2.80
Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease. J Clin Invest (2001) 2.73
Cell-mediated immunity to intestinal infection. Infect Immun (1980) 2.65
Interferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis. Gut (1995) 2.52
Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease. Infect Immun (1999) 2.50
Cell-mediated immunity to gliadin within the small-intestinal mucosa in coeliac disease. Lancet (1975) 2.41
A major role for matrix metalloproteinases in T cell injury in the gut. J Immunol (1997) 2.13
Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion (2000) 2.09
Hypersensitivity reactions in the small intestine. III. The effects of allograft rejection and of graft-versus-host disease on epithelial cell kinetics. Cell Tissue Kinet (1977) 2.00
Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease. Gut (2007) 1.98
Cytokines in stools of children with inflammatory bowel disease or infective diarrhoea. J Clin Pathol (1993) 1.96
High endothelin-1 immunoreactivity in Crohn's disease and ulcerative colitis. Lancet (1992) 1.88
Interleukin 18 and associated markers of T helper cell type 1 activity in coeliac disease. Gut (2002) 1.82
Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease. Gut (2000) 1.75
Role of bacterial intimin in colonic hyperplasia and inflammation. Science (1999) 1.71
Recent developments in the immunology of inflammatory bowel disease. Scand J Immunol (2000) 1.69
Disruption of sulphated glycosaminoglycans in intestinal inflammation. Lancet (1993) 1.64
T-cell receptor expression in intestinal intra-epithelial lymphocyte subpopulations of normal and athymic mice. Immunology (1989) 1.63
Hypersensitivity reactions in the small intestine. 2. Effects of allograft rejection on mucosal architecture and lymphoid cell infiltrate. Gut (1976) 1.62
Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease. Aliment Pharmacol Ther (2000) 1.61
Critical role for tumor necrosis factor alpha in controlling the number of lumenal pathogenic bacteria and immunopathology in infectious colitis. Infect Immun (2001) 1.60
Yersinia enterocolitica infection in resistant and susceptible strains of mice. Infect Immun (1986) 1.57
A p55 TNF receptor immunoadhesin prevents T cell-mediated intestinal injury by inhibiting matrix metalloproteinase production. J Immunol (1998) 1.53
Gamma/delta T cells and the diagnosis of coeliac disease. Clin Exp Immunol (1991) 1.51
Functional properties of lymphocytes isolated from murine small intestinal epithelium. Immunology (1984) 1.48
Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21. Gut (2006) 1.47
IL-4-regulated enteropathy in an intestinal nematode infection. Eur J Immunol (1998) 1.46
Technique for microdissection and measurement in biopsies of human small intestine. J Clin Pathol (1977) 1.44
Changes in the rate of crypt epithelial cell proliferation and mucosal morphology induced by a T-cell-mediated response in human small intestine. Gastroenterology (1990) 1.43
Enhancing Lamina propria Th1 cell responses with interleukin 12 produces severe tissue injury. Gastroenterology (1999) 1.41
Tumor necrosis factor, interleukin-1, and interleukin-6 in normal human pregnancy. Am J Obstet Gynecol (1993) 1.37
The development of gut associated lymphoid tissue in the terminal ileum of fetal human intestine. Clin Exp Immunol (1986) 1.36
Characterization of the mucosal cell-mediated immune response in IL-2 knockout mice before and after the onset of colitis. Immunology (1997) 1.33
T cell subclasses in fetal human ileum. Clin Exp Immunol (1986) 1.31
Isolation and functional characteristics of adherent phagocytic cells from mouse Peyer's patches. Immunology (1982) 1.31
T-cell activation can induce either mucosal destruction or adaptation in cultured human fetal small intestine. Gastroenterology (1993) 1.29
Gamma/delta T cells in the gut epithelium. Gut (1990) 1.27
TGF-beta1 and Smad7 in the regulation of IBD. Mucosal Immunol (2008) 1.26
Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures. Gut (2009) 1.22
Decreased mucosal interleukin-4 (IL-4) production in gut inflammation. J Clin Pathol (1994) 1.22
T cells orchestrate intestinal mucosal shape and integrity. Immunol Today (1999) 1.21
Effects of local delayed hypersensitivity on the small intestine. Ciba Found Symp (1978) 1.20
Interactions between stromal cell--derived keratinocyte growth factor and epithelial transforming growth factor in immune-mediated crypt cell hyperplasia. J Clin Invest (1998) 1.19
Role of interferon alpha in promoting T helper cell type 1 responses in the small intestine in coeliac disease. Gut (2001) 1.19
Polymeric nutrition as the primary therapy in children with small bowel Crohn's disease. Aliment Pharmacol Ther (1994) 1.18
Immune mechanisms in chronic inflammatory bowel disease. Ann Allergy (1994) 1.18
Stimulation of mucosal T cells in situ with anti-CD3 antibody: location of the activated T cells and their distribution within the mucosal micro-environment. Clin Exp Immunol (1988) 1.17
Tumour necrosis factor in the bronchoalveolar secretions of infants with the respiratory distress syndrome and the effect of dexamethasone treatment. Thorax (1992) 1.17
Activation of lamina propria T cells induces crypt epithelial proliferation and goblet cell depletion in cultured human fetal colon. Gut (1992) 1.17
Heterogeneity of non-lymphoid cells expressing HLA-D region antigens in human fetal gut. Clin Exp Immunol (1987) 1.15
Suppression of T cell-mediated injury in human gut by interleukin 10: role of matrix metalloproteinases. Gastroenterology (1998) 1.14
Cytotoxic alpha/beta+ and gamma/delta+ T cells in murine intestinal epithelium. Eur J Immunol (1990) 1.14
Human Peyer's patch T cells are sensitized to dietary antigen and display a Th cell type 1 cytokine profile. J Immunol (2000) 1.11
Interpretation of single progesterone measurement in diagnosis of anovulation and defective luteal phase: observations on analysis of the normal range. Br Med J (Clin Res Ed) (1984) 1.10
Small intestinal epithelial cell kinetics and protozoal infection in mice. Gastroenterology (1978) 1.10
Requirement for a bacterial flora before mice generate cells capable of mediating the delayed hypersensitivity reaction to sheep red blood cells. J Immunol (1979) 1.09
Keratinocyte growth factor in inflammatory bowel disease. Increased mRNA transcripts in ulcerative colitis compared with Crohn's disease in biopsies and isolated mucosal myofibroblasts. Am J Pathol (1997) 1.07
Lymphokine production by mitogen and antigen activated mouse intraepithelial lymphocytes. Cell Immunol (1986) 1.05
Activation of mucosal V beta 3+ T cells and tissue damage in human small intestine by the bacterial superantigen, Staphylococcus aureus enterotoxin B. Eur J Immunol (1993) 1.05
The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease. Mucosal Immunol (2011) 1.04
Expression of intimin gamma from enterohemorrhagic Escherichia coli in Citrobacter rodentium. Infect Immun (2000) 1.04
The effect of treatment on lymphokine-secreting cells in the intestinal mucosa of children with Crohn's disease. Aliment Pharmacol Ther (1995) 1.03
Selective death of T cell receptor gamma/delta+ intraepithelial lymphocytes by apoptosis. Eur J Immunol (1990) 1.03
Regional variation in the proliferative rate and lifespan of alpha beta TCR+ and gamma delta TCR+ intraepithelial lymphocytes in the murine small intestine. Immunology (1995) 1.02
Contact sensitivity in the germ-free mouse. J Reticuloendothel Soc (1978) 1.01
Expression of the VLA family of integrins in human intestine. J Pathol (1990) 1.01
Intestinal nematode infections in children: the pathophysiological price paid. Parasitology (1992) 1.01
Breakdown of tolerance to the intestinal bacterial flora in inflammatory bowel disease (IBD) Clin Exp Immunol (1995) 1.00
Limit dilution analysis of mast cell precursor frequency in the gut epithelium of normal and Trichinella spiralis infected mice. Parasite Immunol (1986) 1.00
Manipulation of cytokines in the management of patients with inflammatory bowel disease. Ann Med (2000) 0.99
Are placental lakes of any clinical significance? Placenta (2002) 0.98
Functional characterization of Con A-responsive Lyt2-positive mouse small intestinal intraepithelial lymphocytes. Immunology (1986) 0.98
TNF alpha secreting cells in normal and diseased human intestine. Adv Exp Med Biol (1995) 0.98
Proteolytic degradation of intestinal mucosal extracellular matrix after lamina propria T cell activation. Gut (1996) 0.96
Immunosuppression caused by antigen feeding II. Suppressor T cells mask Peyer's patch B cell priming to orally administered antigen. Eur J Immunol (1983) 0.96
Matrix metalloproteinases and their inhibitors in the nasal mucosa of patients with perennial allergic rhinitis. J Allergy Clin Immunol (2001) 0.96
Regulation of the T helper cell type 1 transcription factor T-bet in coeliac disease mucosa. Gut (2004) 0.96
Systemic administration of the chemokine macrophage inflammatory protein 1alpha exacerbates inflammatory bowel disease in a mouse model. Gut (2005) 0.95